Calf management and welfare in the Canadian and US dairy industries: Where do we go from here?

被引:10
作者
Roche, S. [1 ,2 ]
Renaud, D. L. [1 ]
Bauman, C. A. [1 ]
Lombard, J. [3 ]
Short, D. [4 ]
Saraceni, J. [2 ]
Kelton, D. F. [1 ]
机构
[1] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada
[2] ACER Consulting, Guelph, ON N1G 5L3, Canada
[3] USDA Anim & Plant Hlth Inspect Serv Vet Serv, Field Epidemiol Invest Serv, Ft Collins, CO 80526 USA
[4] USDA Anim & Plant Hlth Inspection Serv Vet Serv, Ctr Epidemiol & Anim Hlth, Natl Anim Hlth Monitoring Syst, Ft Collins, CO 80526 USA
关键词
benchmarking; welfare; National Dairy Study; National Animal Health Monitoring System (NAHMS); pain management; LONG-TERM PRODUCTIVITY; CALVES FED MILK; RISK-FACTORS; COLOSTRUM MANAGEMENT; RESPIRATORY-DISEASE; REPLACEMENT HEIFERS; PASSIVE-IMMUNITY; WEIGHT GAINS; CALVING EASE; MORTALITY;
D O I
10.3168/jds.2022-22793
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The objective of this narrative review was to com-pare the results of the 2015 Canadian National Dairy Study and the 2014 US National Animal Health Moni-toring System (NAHMS) Dairy Studies, with a specific focus on calf management and welfare, and to interpret these findings within more recent calf health research to describe where we need to go next in the North American dairy industry. Situating results of periodic national studies within the context of past and recent research provides an opportunity to gauge adoption of recommendations and best practices and to help iden-tify persistent and new challenges that the industry is wrestling with to help guide research needs. Through this review of the 2 national studies, we identified sev-eral strengths of the Canadian and US dairy industries. In each area of calf health management, improvements relative to previous NAHMS studies and the published literature have been found in the level of mortality, amount of colostrum fed, housing, and the number of producers using pain control for disbudding and de -horning. There were, however, some areas that present clear opportunities for improvement. Specifically, al-though mortality levels have improved, a large number of calves die at birth, within the first 48 h of life, and during the preweaning period. To improve the health of calves in early life, producers could look at feeding high-quality colostrum at 10% of body weight in the first feeding, as well as feeding a larger amount of milk during the preweaning period. The barriers to mak-ing these management changes and improving overall calf health need to be identified in future studies. The majority of preweaning calves in Canada and the United States are housed in individual housing. This represents a clear opportunity for improvement because recent research has identified the positive aspects of group housing. Finally, with respect to pain control, improvements are needed (particularly in the United States) to ensure that pain management is provided when disbudding and dehorning calves. Although the science is clear on pain management, discussions with producers are needed to identify reasons for the lack of uptake.
引用
收藏
页码:4266 / 4274
页数:9
相关论文
共 44 条
  • [21] The Current State of Knowledge on the Industrial Epidemiologic Transition: Where Do We Go from Here?
    Gage, Timothy B.
    MODERN ENVIRONMENTS AND HUMAN HEALTH: REVISITING THE SECOND EPIDEMIOLOGIC TRANSITION, 2014, : 377 - 392
  • [22] Where do we go from here? Moving toward an integrated approach to family violence
    Slep, AMS
    Heyman, RE
    AGGRESSION AND VIOLENT BEHAVIOR, 2001, 6 (2-3) : 353 - 356
  • [23] Admission hyperglycemia in sepsis is associated with poor outcomes: where do we go from here?
    Szumita, Paul M.
    Gilmore, James F.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (07) : E567 - E570
  • [24] What have we learned from the German COPD cohort COSYCONET and where do we go from here?
    Kahnert, Kathrin
    Fischer, Carolina
    Alter, Peter
    Trudzinski, Franziska
    Welte, Tobias
    Behr, Juergen
    Herth, Felix
    Kauczor, Hans-Ulrich
    Bals, Robert
    Watz, Henrik
    Rabe, Klaus
    Soehler, Sandra
    Kokot, Inge
    Vogelmeier, Claus
    Joerres, Rudolf
    PNEUMOLOGIE, 2023, 77 (02): : 81 - 93
  • [25] Red cell transfusion in elective cardiac surgery patients: where do we go from here?
    Slight, R. D.
    Nzewi, O.
    McClelland, D. B. L.
    Mankad, P. S.
    BRITISH JOURNAL OF ANAESTHESIA, 2009, 102 (03) : 294 - 296
  • [26] The role of VEGF in triple-negative breast cancer: where do we go from here?
    Dent, S. F.
    ANNALS OF ONCOLOGY, 2009, 20 (10) : 1615 - 1617
  • [27] Adolescents and young adults with HIV and unsuppressed viral load: where do we go from here?
    Rakhmanina, Natella
    Foster, Caroline
    Agwu, Allison
    CURRENT OPINION IN HIV AND AIDS, 2024, 19 (06) : 368 - 376
  • [28] Translating the PIRO staging system concept into clinical practice: Where do we go from here?
    Soares, Marcio
    Lisboa, Thiago
    Salluh, Jorge I. F.
    CRITICAL CARE MEDICINE, 2011, 39 (02) : 408 - 409
  • [29] EPIDEMIOLOGIC RESEARCH ON INTERPERSONAL VIOLENCE AND COMMON PSYCHIATRIC DISORDERS: WHERE DO WE GO FROM HERE?
    Cerda, Magdalena
    DiGangi, Julia
    Galea, Sandro
    Koenen, Karestan
    DEPRESSION AND ANXIETY, 2012, 29 (05) : 359 - 385
  • [30] Selecting lung cancer screenees using risk prediction models where do we go from here
    Tammemaegi, Martin C.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (03) : 243 - 253